Abivax (ABVX) Shares Outstanding (2023 - 2025)

Abivax's Shares Outstanding history runs 3 years deep, the most recent figure standing at $91.4 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 35.05% year-over-year to $91.4 million; the TTM figure through Dec 2025 stood at $91.4 million (up 35.05% YoY), while the FY2025 annual figure was $91.4 million, up 35.05% from the prior year.
• Shares Outstanding was $91.4 million for Q4 2025 at Abivax, up from $67.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $91.4 million in Q4 2025 to a low of $6048.3 in Q1 2025.
• Historically, Shares Outstanding has averaged $31.8 million across 3 years, with a median of $7516.2 in 2025.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding slipped 0.02% in 2024, then soared 35.05% in 2025.
• A 3-year view of Shares Outstanding shows it stood at $67.7 million in 2023, then dropped by 0.02% to $67.7 million in 2024, then jumped by 35.05% to $91.4 million in 2025.
• The last three Shares Outstanding figures came in at $91.4 million (Q4 2025), $67.7 million (Q4 2024), and $67.7 million (Q4 2023), per Business Quant data.